Opinion Mohamed is a passionate Blockchain enthusiast who is committed to helping grow the Blockchain ecosystem around the world. Here he talks about healthcare’s slow adoption of technology and the challenges that come with hefty privacy regulation of patient data.  The life-and-death nature of the industry might be a factor of…

Malaysia How Malaysia is setting itself up to provide biosimilars across the Islamic world as well as Asia.   Inno Bio Ventures, a Malaysian state-owned company originally set up to create drug security by ensuring that the country was self-sufficient in terms of medicine supply, has been making its first moves…

Spain Although death rates due to cardiovascular diseases in Spain are among the lowest in the EU, they represent the main cause of death in Spain, accounting for 30% of all deaths in 2014 (33% of deaths among women and 27% among men). Cancer is the second most important cause of…

Patients There are around 2 billion people in the world that do not have access to the medicines they need. This week the 2018 Access to Medicine Index was published revealing that there is a handful of pharmaceutical companies developing the bulk of urgently needed new medicines for the poor. The…

Mexico Cristobal Thompson is the Executive Director at AMIIF (Asociacion Mexicana de Industrias de Investigacion Farmaceutica). The AMIIF represents more than 60 global companies with the aim of contributing to improving health in Mexico through innovative medicine. Here Cristobal discusses Mexico’s regulatory landscape and the countries advances in healthcare.    Mexico has…

Karim Babay is Chairman & CEO of HealthSapiens, a nationwide healthcare provider that delivers on-demand access to healthcare anytime, anywhere, via mobile devices, the internet, video and phone. Here he discusses the need for more price transparency within healthcare systems so that consumers can make informed choices that save them…

Algeria With stiffening up of local content requirements well underway, many multinational drug developers seeking to introduce their therapies to the Algerian marketplace have been scrambling to team up with the handful of indigenous CMOs that possess the requisite quality standards and reputations to handle their brands. Here is a selection…

Malaysia Malaysia’s multi-ethnic population, disease burden, medical infrastructure and research speed, combined with its population’s proficiency in English, make the Southeast Asian nation a potentially excellent regional clinical trials destination.   We have a population of 32 million which represents a third of the world’s genomics Dr Akhmal Yusof, CRM Dr…

Opinion Richard Saynor, Senior Vice President, Classic and Established Products at GSK urges big pharma to weigh in on improving global health and well-being to achieve the United Nations Sustainable Development Goals.  On the part of pharmaceutical companies, we have a responsibility to help people gain access to high-quality healthcare and…

South Korea South Korea’s proposed Moon Jae-In Care has been subject to both praise and protest this year. President Moon Jae-in’s plan dubbed “Moon Care” will be implemented in stages throughout 2022 and pledges to expand healthcare coverage to cover 70 percent of the people’s costs. Korea currently runs on a health…

China China’s stupendous economic resurgence over the past four decades never ceases to awe, but what has captured attention in recent years has been the country’s international awakening. Against a nasty backdrop of intensifying populist nationalism, right-wing radicalism and trade protectionism in many advanced economies, Chinese President Xi Jinping’s surprising 2017…

China Cash has always ruled the start-up world and when it comes to the healthcare and life sciences sphere, the heavy investment required for R&D and the long timelines make it even more so. Luckily, China is now the second-largest VC market in the world, and a recent Preqin report highlighted that USD 65…